StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2020, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 21 Feb 2018 06:13:53 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Merck (MRK) to Acquire Viralytics for $394 Million http://www.streetinsider.com/Corporate+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html for the full story. http://www.streetinsider.com/Corporate+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Wed, 21 Feb 2018 06:13:53 -0500 MRK VLA VRACY Merck (MRK) to Acquire Viralytics for $394 Million http://www.streetinsider.com/Corporate+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html for the full story. http://www.streetinsider.com/Corporate+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Wed, 21 Feb 2018 06:13:53 -0500 MRK VLA VRACY Merck (MRK) to Acquire Viralytics for $394 Million http://www.streetinsider.com/Corporate+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html for the full story. http://www.streetinsider.com/Corporate+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Wed, 21 Feb 2018 06:13:53 -0500 MRK VLA VRACY Merck (MRK) to Acquire Viralytics for $394 Million http://www.streetinsider.com/Management+Comments/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html for the full story. http://www.streetinsider.com/Management+Comments/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Wed, 21 Feb 2018 06:13:53 -0500 MRK VLA VRACY Merck (MRK) to Acquire Viralytics for $394 Million http://www.streetinsider.com/Management+Comments/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html for the full story. http://www.streetinsider.com/Management+Comments/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Wed, 21 Feb 2018 06:13:53 -0500 MRK VLA VRACY Merck (MRK) to Acquire Viralytics for $394 Million http://www.streetinsider.com/Management+Comments/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html for the full story. http://www.streetinsider.com/Management+Comments/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Wed, 21 Feb 2018 06:13:53 -0500 MRK VLA VRACY Merck (MRK) to Acquire Viralytics for $394 Million http://www.streetinsider.com/Mergers+and+Acquisitions/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Visit StreetInsider.com at http://www.streetinsider.com/Mergers+and+Acquisitions/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html for the full story. http://www.streetinsider.com/Mergers+and+Acquisitions/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Wed, 21 Feb 2018 06:13:53 -0500 MRK VLA VRACY Merck (MRK) to Acquire Viralytics for $394 Million http://www.streetinsider.com/Mergers+and+Acquisitions/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Visit StreetInsider.com at http://www.streetinsider.com/Mergers+and+Acquisitions/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html for the full story. http://www.streetinsider.com/Mergers+and+Acquisitions/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Wed, 21 Feb 2018 06:13:53 -0500 MRK VLA VRACY Merck (MRK) to Acquire Viralytics for $394 Million http://www.streetinsider.com/Mergers+and+Acquisitions/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Visit StreetInsider.com at http://www.streetinsider.com/Mergers+and+Acquisitions/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html for the full story. http://www.streetinsider.com/Mergers+and+Acquisitions/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Wed, 21 Feb 2018 06:13:53 -0500 MRK VLA VRACY Merck (MRK) to Acquire Viralytics for $394 Million http://www.streetinsider.com/Hot+Corp.+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Visit StreetInsider.com at http://www.streetinsider.com/Hot+Corp.+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html for the full story. http://www.streetinsider.com/Hot+Corp.+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Wed, 21 Feb 2018 06:13:53 -0500 MRK VLA VRACY Merck (MRK) to Acquire Viralytics for $394 Million http://www.streetinsider.com/Hot+Corp.+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Visit StreetInsider.com at http://www.streetinsider.com/Hot+Corp.+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html for the full story. http://www.streetinsider.com/Hot+Corp.+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Wed, 21 Feb 2018 06:13:53 -0500 MRK VLA VRACY Merck (MRK) to Acquire Viralytics for $394 Million http://www.streetinsider.com/Hot+Corp.+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Visit StreetInsider.com at http://www.streetinsider.com/Hot+Corp.+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html for the full story. http://www.streetinsider.com/Hot+Corp.+News/Merck+%28MRK%29+to+Acquire+Viralytics+for+%24394+Million/13842979.html Wed, 21 Feb 2018 06:13:53 -0500 MRK VLA VRACY Merck and Viralytics Announce Acquisition Agreement, Expanding Merck’s Leading Immuno-Oncology Pipeline http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html for the full story. http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html Wed, 21 Feb 2018 04:00:00 -0500 A.10118540 A.17475699 A.32238242 MRK VLA VRACY Merck and Viralytics Announce Acquisition Agreement, Expanding Merck’s Leading Immuno-Oncology Pipeline http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html for the full story. http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html Wed, 21 Feb 2018 04:00:00 -0500 A.10118540 A.17475699 A.32238242 MRK VLA VRACY Merck and Viralytics Announce Acquisition Agreement, Expanding Merck’s Leading Immuno-Oncology Pipeline http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html for the full story. http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html Wed, 21 Feb 2018 04:00:00 -0500 A.10118540 A.17475699 A.32238242 MRK VLA VRACY Merck and Viralytics Announce Acquisition Agreement, Expanding Merck’s Leading Immuno-Oncology Pipeline http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html for the full story. http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html Wed, 21 Feb 2018 04:00:00 -0500 A.10118540 A.17475699 A.32238242 MRK VLA VRACY Merck and Viralytics Announce Acquisition Agreement, Expanding Merck’s Leading Immuno-Oncology Pipeline http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html for the full story. http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html Wed, 21 Feb 2018 04:00:00 -0500 A.10118540 A.17475699 A.32238242 MRK VLA VRACY Merck and Viralytics Announce Acquisition Agreement, Expanding Merck’s Leading Immuno-Oncology Pipeline http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html for the full story. http://www.streetinsider.com/Press+Releases/Merck+and+Viralytics+Announce+Acquisition+Agreement%2C+Expanding+Merck%E2%80%99s+Leading+Immuno-Oncology+Pipeline/13842594.html Wed, 21 Feb 2018 04:00:00 -0500 A.10118540 A.17475699 A.32238242 MRK VLA VRACY Viralytics Completes $28 million Placement -- SPP to Follow http://www.streetinsider.com/Press+Releases/Viralytics+Completes+%2428+million+Placement+--+SPP+to+Follow/11149228.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Viralytics+Completes+%2428+million+Placement+--+SPP+to+Follow/11149228.html for the full story. http://www.streetinsider.com/Press+Releases/Viralytics+Completes+%2428+million+Placement+--+SPP+to+Follow/11149228.html Mon, 14 Dec 2015 06:00:00 -0500 A.01857600 A.17475699 VLA VRACY Viralytics Completes $28 million Placement -- SPP to Follow http://www.streetinsider.com/Press+Releases/Viralytics+Completes+%2428+million+Placement+--+SPP+to+Follow/11149228.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Viralytics+Completes+%2428+million+Placement+--+SPP+to+Follow/11149228.html for the full story. http://www.streetinsider.com/Press+Releases/Viralytics+Completes+%2428+million+Placement+--+SPP+to+Follow/11149228.html Mon, 14 Dec 2015 06:00:00 -0500 A.01857600 A.17475699 VLA VRACY Viralytics Completes $28 million Placement -- SPP to Follow http://www.streetinsider.com/Press+Releases/Viralytics+Completes+%2428+million+Placement+--+SPP+to+Follow/11149228.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Viralytics+Completes+%2428+million+Placement+--+SPP+to+Follow/11149228.html for the full story. http://www.streetinsider.com/Press+Releases/Viralytics+Completes+%2428+million+Placement+--+SPP+to+Follow/11149228.html Mon, 14 Dec 2015 06:00:00 -0500 A.01857600 A.17475699 VLA VRACY Viralytics Completes $28 million Placement -- SPP to Follow http://www.streetinsider.com/Press+Releases/Viralytics+Completes+%2428+million+Placement+--+SPP+to+Follow/11149228.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Viralytics+Completes+%2428+million+Placement+--+SPP+to+Follow/11149228.html for the full story. http://www.streetinsider.com/Press+Releases/Viralytics+Completes+%2428+million+Placement+--+SPP+to+Follow/11149228.html Mon, 14 Dec 2015 06:00:00 -0500 A.01857600 A.17475699 VLA VRACY Viralytics and Merck & Co., Inc., Kenilworth, New Jersey, U.S.A. to Collaborate on Combination Clinical Trial of CAVATAK(TM) and KEYTRUDA(R) in Lung and Bladder Cancer http://www.streetinsider.com/Press+Releases/Viralytics+and+Merck+%26amp%3B+Co.%2C+Inc.%2C+Kenilworth%2C+New+Jersey%2C+U.S.A.+to+Collaborate+on+Combination+Clinical+Trial+of+CAVATAK%28TM%29+and+KEYTRUDA%28R%29+in+Lung+and+Bladder+Cancer/11045405.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Viralytics+and+Merck+%26amp%3B+Co.%2C+Inc.%2C+Kenilworth%2C+New+Jersey%2C+U.S.A.+to+Collaborate+on+Combination+Clinical+Trial+of+CAVATAK%28TM%29+and+KEYTRUDA%28R%29+in+Lung+and+Bladder+Cancer/11045405.html for the full story. http://www.streetinsider.com/Press+Releases/Viralytics+and+Merck+%26amp%3B+Co.%2C+Inc.%2C+Kenilworth%2C+New+Jersey%2C+U.S.A.+to+Collaborate+on+Combination+Clinical+Trial+of+CAVATAK%28TM%29+and+KEYTRUDA%28R%29+in+Lung+and+Bladder+Cancer/11045405.html Fri, 06 Nov 2015 06:00:00 -0500 A.17475699 A.60001765 VLA VRACY Viralytics and Merck & Co., Inc., Kenilworth, New Jersey, U.S.A. to Collaborate on Combination Clinical Trial of CAVATAK(TM) and KEYTRUDA(R) in Lung and Bladder Cancer http://www.streetinsider.com/Press+Releases/Viralytics+and+Merck+%26amp%3B+Co.%2C+Inc.%2C+Kenilworth%2C+New+Jersey%2C+U.S.A.+to+Collaborate+on+Combination+Clinical+Trial+of+CAVATAK%28TM%29+and+KEYTRUDA%28R%29+in+Lung+and+Bladder+Cancer/11045405.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Viralytics+and+Merck+%26amp%3B+Co.%2C+Inc.%2C+Kenilworth%2C+New+Jersey%2C+U.S.A.+to+Collaborate+on+Combination+Clinical+Trial+of+CAVATAK%28TM%29+and+KEYTRUDA%28R%29+in+Lung+and+Bladder+Cancer/11045405.html for the full story. http://www.streetinsider.com/Press+Releases/Viralytics+and+Merck+%26amp%3B+Co.%2C+Inc.%2C+Kenilworth%2C+New+Jersey%2C+U.S.A.+to+Collaborate+on+Combination+Clinical+Trial+of+CAVATAK%28TM%29+and+KEYTRUDA%28R%29+in+Lung+and+Bladder+Cancer/11045405.html Fri, 06 Nov 2015 06:00:00 -0500 A.17475699 A.60001765 VLA VRACY Viralytics and Merck & Co., Inc., Kenilworth, New Jersey, U.S.A. to Collaborate on Combination Clinical Trial of CAVATAK(TM) and KEYTRUDA(R) in Lung and Bladder Cancer http://www.streetinsider.com/Press+Releases/Viralytics+and+Merck+%26amp%3B+Co.%2C+Inc.%2C+Kenilworth%2C+New+Jersey%2C+U.S.A.+to+Collaborate+on+Combination+Clinical+Trial+of+CAVATAK%28TM%29+and+KEYTRUDA%28R%29+in+Lung+and+Bladder+Cancer/11045405.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Viralytics+and+Merck+%26amp%3B+Co.%2C+Inc.%2C+Kenilworth%2C+New+Jersey%2C+U.S.A.+to+Collaborate+on+Combination+Clinical+Trial+of+CAVATAK%28TM%29+and+KEYTRUDA%28R%29+in+Lung+and+Bladder+Cancer/11045405.html for the full story. http://www.streetinsider.com/Press+Releases/Viralytics+and+Merck+%26amp%3B+Co.%2C+Inc.%2C+Kenilworth%2C+New+Jersey%2C+U.S.A.+to+Collaborate+on+Combination+Clinical+Trial+of+CAVATAK%28TM%29+and+KEYTRUDA%28R%29+in+Lung+and+Bladder+Cancer/11045405.html Fri, 06 Nov 2015 06:00:00 -0500 A.17475699 A.60001765 VLA VRACY